Coriodermina
A Cuban-developed topical medication from human placental extract that regulates skin cell growth and reduces inflammation in psoriasis.
Coriodermina
A Cuban-developed topical medication from human placental extract that regulates skin cell growth and reduces inflammation in psoriasis.
Coriodermina at a glance
Coriodermina is a Cuban-developed topical (applied to the skin) medication for psoriasis. Made from human placental extract, it works by regulating skin cell growth and reducing inflammation. This offers an alternative or addition to conventional psoriasis treatments, particularly for patients seeking options different from corticosteroid-based creams.
How It Works
Coriodermina contains growth factors and other bioactive compounds derived from human placental extract. In psoriasis, skin cells multiply too quickly, resulting in thick, red, scaly patches (plaques). Coriodermina is designed to regulate this excessive skin cell proliferation and reduce inflammation — the two key processes driving psoriasis plaques. This mechanism is different from conventional corticosteroid or vitamin D-based creams.
Treatment Protocol
Coriodermina is applied to the affected areas of skin. Treatment may be combined with light therapy, moisturizers, and lifestyle recommendations. For more severe cases, systemic (whole-body) treatments may be considered. The treatment plan is tailored to the type and extent of your psoriasis. Treatment is given on an outpatient basis — you receive the medication and application instructions, allowing you to continue treatment at home.
Conditions Treated
Clinical Evidence
Coriodermina was developed at Cuba's Placental Histotherapy Center alongside Melagenin Plus. It is applied as a topical treatment and is particularly suited for patients seeking alternatives to corticosteroid-based creams. Cuban dermatologists provide a full assessment and a personalized treatment plan. As with all psoriasis treatments, results vary by individual.
Availability
Coriodermina is a Cuban-developed product available through SMC Salud's international patient services. Patients receive the medication and application instructions during their stay in Cuba, allowing continued treatment at home. A dermatological evaluation determines whether it is right for you.
Frequently Asked Questions
Related Information
Medically Reviewed
SMC Salud Medical Review Board
Board-certified physicians and specialists in oncology, neurology, dermatology, and endocrinology
Last reviewed: January 15, 2025
This content has been medically reviewed by qualified physicians and follows SMC Salud's editorial policy for health information. Medical content is for informational purposes and does not replace professional medical advice.
Ready to Learn More?
Take the next step. Our international patient coordinators are here to help you understand your options.
Treatment suitability depends on specialist evaluation. Individual treatment plans apply.